Cannabix Technologies, Inc. (BLO/ BLOZF)

BLO_logoCannabix Technologies, Inc. is a technology company that has developed Cannabix Marijuana Breathalyzer for law enforcement. Formerly named West Point Resources, Inc., Cannabix has the exclusive licenses for Cannabix Marijuana Breathalyzer in North America.

The Cannabix Marijuana Breathalyzer is an innovative drug-impairment detection device created based on a breath-testing technology developed in Sweden. This technology underwent rigorous clinical researches to be become highly effective in testing individuals for their recent consumption of Tetrahydrocannabinol (THC), marijuana’s psychoactive component that causes intoxication.

Cannabix Technologies, Inc. focuses on advancing their patent-pending drug-impairment detection technology to provide law enforcement personnel with enhanced marijuana detection capability. This cutting-edge technology will allow law enforcement to efficiently detect marijuana-related impaired driving offenses on roadsides in North America at a time when many jurisdictions are legalizing cannabis use.

The Cannabix Marijuana Breathalyzer is used at roadsides to detect traces of THC in the system of drivers believed to be intoxicated by marijuana. This innovative device may also be used for other applications, including THC testing on employees in workplaces where impairment by marijuana is considered hazardous.

Based in Vancouver, BC, Cannabix Technologies, Inc. is traded on the Canadian Securities Exchange under the symbol BLO, and on the OTC market under the stock symbol BLOZF. The company’s leaders are Kal Malhi, President & Director; Raj Attariwala, Chief Engineer; Bruce Goldberger, Senior Advisor; Ray Mlait, CEO & Director; Jay Bala, Director; Alex Kanayev, Director; Thomas Clarke, Director; and Andrew Davies, Advisor.

Cannabix Technologies, Inc.

7934 Government Rd
Burnaby, BC, V5A 2E2

Phone: (604) 551-7831
Email: info@Cannabixtechnologies.com
Website: http://www.cannabixtechnologies.com/


Yahoo! Finance: BLOZF News

Latest Financial News for BLOZF

Cannabix Technologies Makes Advances with Marijuana Breathalyzer Development and THC Breath Capture

The Cannabix Marijuana Breathalyzer is being developed to provide law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, July 15, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company” or “Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that Company scientists have made significant advancements with analyte in breath capture and FAIMS cell development.  Cannabix scientists have been optimizing the breath / sample capture procedures and technology to maximize ∆9-tetrahydrocannabinol (“THC”) analyte capture from human breath.

Cannabix Technologies Makes Advances with Marijuana Breathalyzer Development and Renews Research with Yost Group

The Cannabix Marijuana Breathalyzer system is being developed to give law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, May 29, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer for law enforcement and the workplace, is pleased to report that Company engineers have made a significant breakthrough with the ionization module which is a vital component of the breathalyzer device, where breath samples are ionized prior to entrance into the FAIMS cell. The Company also reports that it has been steadily progressing with human breath testing at its Vancouver, BC, based lab with its FAIMS (field asymmetric waveform ion mobility spectrometry) ∆9-tetrahydrocannabinol (“THC”) detection device and breath collection unit (“BCU”).

Cannabix Technologies Adds Dr. Randall Purves as Scientific Advisor

The Cannabix Marijuana Breathalyzer system is being developed to give law enforcement and employers a tool to enforce public safety. VANCOUVER, British Columbia, May 13, 2019 (GLOBE NEWSWIRE) -- Cannabix Technologies Inc. (CSE:BLO) (OTC PINK: BLOZF) (the “Company”) is pleased to announce that Dr. Randy Purves has been appointed as a Scientific Advisor to Cannabix Technologies Inc. Dr. Purves is one of the world’s foremost experts in the development of FAIMS (high-field asymmetric waveform ion mobility spectrometry) instrumentation and applications. Dr. Purves is a pioneer in developing FAIMS technology and in 2001 he co-founded Ionalytics, an instrument company specializing in FAIMS devices for use with mass spectrometry.

Approved Roadside Saliva Test Faces Court Challenge in Canada -- CFN Media

Seattle, Washington--(Newsfile Corp. - April 30, 2019) - CFN Media Group ("CFN Media"), the leading agency and financial media network dedicated to the North American cannabis industry, announces the publication of an article discussing Cannabix Technologies Inc. (CSE: BLO) (OTC: BLOZF) and its development of the Cannabix Marijuana Breathalyzer, seeking to provide consistent, convenient, and accurate THC detection for both law enforcement and workplace applications.In August of 2018 the Canadian federal government approved ...

Cannabix Technologies Provides Update on Marijuana Breathalyzer Development

VANCOUVER, British Columbia, April 17, 2019 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana.